about
Overview of clinical lung transplantationFunctional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production.Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig.Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectorsNovel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning.Local long-term expression of lentivirally delivered IL-10 in the lung attenuates obliteration of intrapulmonary allograft airways.Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study.Ex-vivo lung perfusion: the model for the organ reconditioning hub.Increased levels of interleukin-1β and tumor necrosis factor-α in donor lungs rejected for transplantation.Treatment choices and outcomes of patients with manometrically diagnosed achalasia.Management of severe asymmetric pectus excavatum complicating aortic repair in a patient with Marfan's syndrome.Design, production, and characterization of an engineered biotin ligase (BirA) and its application for affinity purification of staphylokinase produced from Bacillus subtilis via secretion.Normothermic acellular ex vivo liver perfusion (NEVLP) reduces liver and bile duct in DCD liver grafts.Functional repair of human donor lungs by IL-10 gene therapy.Lentivirus IL-10 gene therapy down-regulates IL-17 and attenuates mouse orthotopic lung allograft rejection.Machine treatment of adult respiratory distress syndrome: Rinse or wash cycle?Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center.Physiologic assessment of the ex vivo donor lung for transplantation.Towards Donor Lung Recovery - Gene Expression Changes During Ex Vivo Lung Perfusion of Human Lungs.Technique for prolonged normothermic ex vivo lung perfusion.The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.miR-145 expression enhances integrin expression in SK-GT-4 cell line by down-regulating c-Myc expression.Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis.Metachronous or synchronous primary lung cancer in the era of computed tomography surveillanceTrans-diaphragmatic gastro-ventricular fistulaNormothermic ex vivo lung perfusion in clinical lung transplantationNormothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantationKinetics of lactate metabolism during acellular normothermic ex vivo lung perfusionRejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organsLung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusionEx vivo lung perfusion and reconditioningIntroducing the concept of semielective lung transplantation through the use of ex vivo lung perfusionPig lung transplant survival modelIntraoperative extracorporeal support during lung transplantation in patients bridged with venovenous extracorporeal membrane oxygenationIncidence of Ipsilateral Side Recurrence After Open or Video-Assisted Thoracic Surgery Resection of Colorectal Lung MetastasesCommentary: Solitary Fibrous Tumor of the Esophagus-Rare but With Typical CharacteristicsInitial lung transplantation experience with uncontrolled donation after cardiac death in North America
P50
Q28661021-648C0A61-3521-446B-B3B9-0CE6DA181CA3Q34101697-E2591476-F7AC-483B-81BA-2DC3244D2056Q36014104-C8A8E2A1-1642-4AED-9290-90AB7D8343C9Q37473562-DDAF8913-F571-4730-B2CF-4DADA8A9A9CFQ37867758-BA29CA4B-BB8D-4CA0-969E-74F0D852025BQ38335213-66478713-0AA5-4CD2-A5BE-6D0EEDC040CCQ39170806-974C9DCE-9DC0-4A28-9410-63983DADF839Q39182024-B06BA616-12FC-48EA-9C1B-C4120CB1F017Q39793482-25F71EE9-565A-4F4F-AB41-C5E26F17083BQ41159373-8A86E0B0-87AD-4195-8EBF-66029EFFA03AQ42742821-49B1C300-D24B-440D-A1D0-44EF7E78F2EAQ43939572-59F43254-B859-4589-BD40-8DB345EE861FQ44425736-218E771B-9C2D-493D-B4FC-966C546B7FB6Q45858165-6D3824ED-8673-4E64-82B1-AA8091F721C7Q45886907-617B0A4D-DD5D-44F1-908E-F3B003F52778Q47178031-E6DB4CA0-2A97-4AC3-AB2B-4930579C3B41Q47297459-97DE1B1C-F938-4592-8977-F01B97B6BF53Q48378351-5BE66A50-937A-4367-9ABF-6E9A93544D59Q49989840-652DE10F-188F-4001-B28F-A1FC37D861FDQ50626024-4A826BF5-39A5-4A65-949B-B0CE4E475A03Q51637351-8929D5A2-6EBB-4138-AF0E-96BAA73F925CQ52720476-7B1D13C0-BD0E-42BC-A24D-3D02955E3DAAQ53288162-F4D4FC58-A403-4CC2-B46A-DEB4CE4BB6FAQ58581486-04C14CCA-404E-4EBB-8BE8-3E25C0AEB2CDQ58581925-6753A097-39DC-4A49-B866-356444E954B8Q83848924-0C3C5075-DD2B-48AA-A163-F49728A7877EQ84371019-A9B111BA-302E-4DA1-BE91-51FD349020E8Q84963734-4724D13D-057C-4FC5-A92A-7F6DF9C081E7Q85895871-BDE23BF5-FDD4-4939-9DF7-196CDC024664Q86931375-D6C14680-8EB4-43EC-92C5-1645FA105A3AQ87075412-06A6FC3A-A693-4E39-8698-D14B628E0DECQ89367640-37500F70-9179-4D5C-A21D-4225DB4CD9F3Q90724236-D4CA84A4-A5D1-4782-9C6F-ACC20A798EFCQ91334172-8CEA053A-DC8A-4889-AA78-BCEFD5EFF9D2Q92737529-BB049FB3-0CE9-4BF7-AC8E-F35525EDE10AQ92818198-12F99180-256E-4B50-B53D-0C0417C78F30Q93032332-0A1BEF16-3EA0-4C85-BAAD-63B8FACFD519
P50
description
researcher
@en
wetenschapper
@nl
name
Jonathan C Yeung
@en
Jonathan C Yeung
@nl
type
label
Jonathan C Yeung
@en
Jonathan C Yeung
@nl
prefLabel
Jonathan C Yeung
@en
Jonathan C Yeung
@nl
P106
P31
P496
0000-0001-5759-3028